Matches in Wikidata for { <http://www.wikidata.org/entity/Q37731321> ?p ?o ?g. }
- Q37731321 description "article científic" @default.
- Q37731321 description "article scientifique" @default.
- Q37731321 description "articolo scientifico" @default.
- Q37731321 description "artigo científico" @default.
- Q37731321 description "artículu científicu espublizáu en 2017" @default.
- Q37731321 description "bilimsel makale" @default.
- Q37731321 description "scientific article published on 28 January 2017" @default.
- Q37731321 description "vedecký článok" @default.
- Q37731321 description "vetenskaplig artikel" @default.
- Q37731321 description "videnskabelig artikel" @default.
- Q37731321 description "vědecký článek" @default.
- Q37731321 description "wetenschappelijk artikel" @default.
- Q37731321 description "wissenschaftlicher Artikel" @default.
- Q37731321 description "наукова стаття, опублікована в січні 2017" @default.
- Q37731321 description "научни чланак" @default.
- Q37731321 description "գիտական հոդված հրատարակված 2017 թվականի հունվարի 28-ին" @default.
- Q37731321 description "مقالة علمية نشرت في 28 يناير 2017" @default.
- Q37731321 name "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 name "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 name "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 type Item @default.
- Q37731321 label "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 label "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 label "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 prefLabel "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 prefLabel "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 prefLabel "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 P1433 Q37731321-2E05A68B-92F4-4B6B-88B9-DF9F7549ABF4 @default.
- Q37731321 P1476 Q37731321-126A8208-8904-4A24-9183-CBA0FF888191 @default.
- Q37731321 P2093 Q37731321-0616CF03-9860-4480-8147-6400D0EBC241 @default.
- Q37731321 P2093 Q37731321-D39B900B-FB83-4478-8C30-9D12EE406144 @default.
- Q37731321 P2093 Q37731321-E480C751-F645-4E35-85E1-8A022D4B0276 @default.
- Q37731321 P275 Q37731321-01fe60a6-1233-49b0-832d-ed2176793714 @default.
- Q37731321 P2860 Q37731321-038E6C81-3FC0-4969-9958-28D46FEE06F7 @default.
- Q37731321 P2860 Q37731321-0AFB8AEA-0DE7-4F98-B4DC-AC18089AA9D4 @default.
- Q37731321 P2860 Q37731321-38AD3EF7-9583-4696-B9E2-E0CCE348085F @default.
- Q37731321 P2860 Q37731321-45B629DA-26FE-4318-A667-5752BCD467E6 @default.
- Q37731321 P2860 Q37731321-54A25028-3903-4025-9C38-5D426FBB0E26 @default.
- Q37731321 P2860 Q37731321-6521683A-C665-4CE8-8311-20F54F502A50 @default.
- Q37731321 P2860 Q37731321-674A55F1-A6FF-423A-AB55-AE77BB2C0BB9 @default.
- Q37731321 P2860 Q37731321-6F639E80-D367-42ED-886B-A6BFA1264306 @default.
- Q37731321 P2860 Q37731321-6F777299-A882-4E91-A525-B8E31E7A4FEC @default.
- Q37731321 P2860 Q37731321-703E5A64-A642-4CBF-A5DE-7F7C83B792DF @default.
- Q37731321 P2860 Q37731321-70DA6301-EE21-406B-97AF-AF2FB18D948E @default.
- Q37731321 P2860 Q37731321-71D1398C-ACF8-446F-AB04-3B5E4EA72F3D @default.
- Q37731321 P2860 Q37731321-8B7D76BC-704B-4A3B-B6B0-E74749B79672 @default.
- Q37731321 P2860 Q37731321-90CBCDA4-89A0-4A8A-B9D6-0F2C4AA0E760 @default.
- Q37731321 P2860 Q37731321-916FFA8D-A94B-4B9D-BE94-08CCCB34C72D @default.
- Q37731321 P2860 Q37731321-A700FAD4-9084-4637-BBD6-844074482979 @default.
- Q37731321 P2860 Q37731321-C405E61F-19EA-427F-9A7B-F2355C803F84 @default.
- Q37731321 P2860 Q37731321-DAC0AEFA-4EA7-44B6-82A0-C7EE2A3115CF @default.
- Q37731321 P2860 Q37731321-E3F6A10C-C947-4B6F-96CB-A88B0452037B @default.
- Q37731321 P2860 Q37731321-F7AA85A0-B870-4026-88D5-045189AEE3FF @default.
- Q37731321 P2860 Q37731321-FF6E0076-D6AA-4C37-A59C-C89EB8D4A9F4 @default.
- Q37731321 P31 Q37731321-BFE51E21-ADA2-4AED-BEEC-CB264915F487 @default.
- Q37731321 P356 Q37731321-22A88D67-CED9-4B52-8F60-7E0A9CB69687 @default.
- Q37731321 P433 Q37731321-EBD348B7-C8E0-4E98-A02A-D4700836CB7E @default.
- Q37731321 P478 Q37731321-02C90AFA-A5E9-452C-9D62-32378C9C3D64 @default.
- Q37731321 P50 Q37731321-DF6FDB5F-755E-442B-8BDE-4952571018C8 @default.
- Q37731321 P577 Q37731321-6E022DDC-B559-4B41-B100-081BFB0CFCEA @default.
- Q37731321 P6216 Q37731321-21ab030d-d162-4e7d-b95a-8238767f8041 @default.
- Q37731321 P698 Q37731321-1F2DBBA9-131B-49A0-AA5A-9A18FF9C0D5C @default.
- Q37731321 P921 Q37731321-0E9E07AB-72EF-4981-AC2C-9090D6468E9F @default.
- Q37731321 P932 Q37731321-4DB17052-243E-4D15-A566-A3818D89AC67 @default.
- Q37731321 P356 PH10010019 @default.
- Q37731321 P698 28134851 @default.
- Q37731321 P1433 Q15750667 @default.
- Q37731321 P1476 "Barriers to the Access of Bevacizumab in Patients with Solid Tumors and the Potential Impact of Biosimilars: A Physician Survey" @default.
- Q37731321 P2093 "Ira Jacobs" @default.
- Q37731321 P2093 "Philip E Lammers" @default.
- Q37731321 P2093 "Thomas Cartwright" @default.
- Q37731321 P275 Q20007257 @default.
- Q37731321 P2860 Q27860681 @default.
- Q37731321 P2860 Q28278736 @default.
- Q37731321 P2860 Q29614302 @default.
- Q37731321 P2860 Q29617568 @default.
- Q37731321 P2860 Q30356434 @default.
- Q37731321 P2860 Q33566222 @default.
- Q37731321 P2860 Q33673144 @default.
- Q37731321 P2860 Q34249816 @default.
- Q37731321 P2860 Q34309684 @default.
- Q37731321 P2860 Q34663877 @default.
- Q37731321 P2860 Q34664272 @default.
- Q37731321 P2860 Q35565315 @default.
- Q37731321 P2860 Q38125609 @default.
- Q37731321 P2860 Q38199478 @default.
- Q37731321 P2860 Q38908352 @default.
- Q37731321 P2860 Q38924494 @default.
- Q37731321 P2860 Q39910421 @default.
- Q37731321 P2860 Q42852805 @default.
- Q37731321 P2860 Q44150789 @default.
- Q37731321 P2860 Q44579933 @default.
- Q37731321 P2860 Q46341615 @default.
- Q37731321 P31 Q13442814 @default.
- Q37731321 P356 "10.3390/PH10010019" @default.
- Q37731321 P433 "1" @default.
- Q37731321 P478 "10" @default.
- Q37731321 P50 Q107013145 @default.
- Q37731321 P577 "2017-01-28T00:00:00Z" @default.
- Q37731321 P6216 Q50423863 @default.